Johnson & Johnson (JNJ) Shares Outstanding (Diluted Average) (2009 - 2026)

Johnson & Johnson has disclosed Shares Outstanding (Diluted Average) across 18 years of filings, most recently posting $2.4 billion for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $2.4 billion, up 0.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 0.88% YoY), and the FY2025 annual result was $2.4 billion, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) came in at $2.4 billion for Q1 2026 at Johnson & Johnson, up from $2.4 billion in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $2.7 billion in Q1 2022 to a low of $2.4 billion in Q2 2025.
• The 5-year median for Shares Outstanding (Diluted Average) is $2.5 billion (2023), against an average of $2.5 billion.
• Across the five-year window, Shares Outstanding (Diluted Average) declined 7.69% in 2024 and gained 0.88% in 2026, its largest moves.
• Johnson & Johnson's Shares Outstanding (Diluted Average) stood at $2.7 billion in 2022, then declined by 3.79% to $2.6 billion in 2023, then retreated by 5.12% to $2.4 billion in 2024, then changed by 0.0% to $2.4 billion in 2025, then gained by 0.65% to $2.4 billion in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $2.4 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.